Evidence map›Paper›PMID 38731896›Full record

ReviewInternational journal of molecular sciences2024

Triggering Degradation of Host Cellular Proteins for Robust Propagation of Influenza Viruses.

Chuan Xia, Ting Wang, Bumsuk Hahm

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Chuan XiaDepartment of Microbiology, College of Basic Medical Sciences, Dalian Medical University, Dalian 116044, China.
Ting WangDepartment of Bioengineering, College of Life Science and Technology, Jinan University, Guangzhou 510632, China.
Bumsuk HahmDepartments of Surgery & Molecular Microbiology and Immunology, University of Missouri, Columbia, MO 65212, USA.ORCID 0000-0002-0083-6129

Funding

Interplay between influenza virus and S1P-metabolizing enzymesR01AI162631 · NIAID · UNIVERSITY OF MISSOURI-COLUMBIA · PI HAHM, BUMSUK · 2021 to 2025
$2.2M
Regulation of host immunity to impact virus persistenceR01AI153076 · NIAID · UNIVERSITY OF MISSOURI-COLUMBIA · PI HAHM, BUMSUK · 2021 to 2025
$2.1M
NIAID NIH HHS R01 AI153076NIAID NIH HHS R01 AI162631NIH HHS 1R01AI153076-03A1NIH HHS 1R01AI162631
6 · The paper itself

Abstract

Following infection, influenza viruses strive to establish a new host cellular environment optimized for efficient viral replication and propagation. Influenza viruses use or hijack numerous host factors and machinery not only to fulfill their own replication process but also to constantly evade the host's antiviral and immune response. For this purpose, influenza viruses appear to have formulated diverse strategies to manipulate the host proteins or signaling pathways. One of the most effective tactics is to specifically induce the degradation of the cellular proteins that are detrimental to the virus life cycle. Here, we summarize the cellular factors that are deemed to have been purposefully degraded by influenza virus infection. The focus is laid on the mechanisms for the protein ubiquitination and degradation in association with facilitated viral amplification. The fate of influenza viral infection of hosts is heavily reliant on the outcomes of the interplay between the virus and the host antiviral immunity. Understanding the processes of how influenza viruses instigate the protein destruction pathways could provide a foundation for the development of advanced therapeutics to target host proteins and conquer influenza.

Indexed as

Host-Pathogen InteractionsOrthomyxoviridaeUbiquitinationVirus ReplicationAnimalsHumansInfluenza, HumanProteolysisinfluenza virusinterferonprotein degradationubiquitinationvirus-host interaction

Identifiers

PMID38731896
PMCPMC11083682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.